Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated:  4/27/2010
Callender Center for Clinical Research
mi
from
Mitchellville, MD
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated: 4/27/2010
Callender Center for Clinical Research
mi
from
Mitchellville, MD
Click here to add this to my saved trials
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Status: Enrolling
Updated:  8/5/2010
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
mi
from
New York, NY
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.
Status: Enrolling
Updated: 8/5/2010
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
mi
from
New York, NY
Click here to add this to my saved trials
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus
Status: Enrolling
Updated:  9/1/2010
Woolfson Eye Institute
mi
from
Atlanta, GA
Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia
Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia or Progressive Keratoconus
Status: Enrolling
Updated: 9/1/2010
Woolfson Eye Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of California, San Francisco
mi
from
San Francisco, CA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of California, San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
National Jewish Health
mi
from
Denver, CO
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Georgetown University School of Medicine
mi
from
Washington,
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Georgetown University School of Medicine
mi
from
Washington,
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Feinberg School of Medicine, Northwestern University
mi
from
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Feinberg School of Medicine, Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Illinois at Chicago, College of Medicine
mi
from
Chicago, IL
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Illinois at Chicago, College of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Boston University School of Medicine
mi
from
Boston, MA
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Michigan Medical School
mi
from
Ann Arbor, MI
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Michigan Medical School
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
Medical University of South Carolina
mi
from
Charleston, SC
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated:  9/16/2010
University of Texas Medical School in Houston
mi
from
Houston, TX
Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)
Mycophenolate vs. Oral Cyclophosphamide in Scleroderma Interstitial Lung Disease (Scleroderma Lung Study II)
Status: Enrolling
Updated: 9/16/2010
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
Palos Verdes Dermatology Associates
mi
from
Rolling Hills Estates, CA
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Palos Verdes Dermatology Associates
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated:  2/18/2011
Berlin Center
mi
from
Boynton Beach, FL
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
Status: Enrolling
Updated: 2/18/2011
Berlin Center
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Casa Grande Regional Medical Center
mi
from
Casa Grande, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Casa Grande Regional Medical Center
mi
from
Casa Grande, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Chandler Regional
mi
from
Chandler, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Chandler Regional
mi
from
Chandler, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Southeast Arizona Medical Center
mi
from
Douglas, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Southeast Arizona Medical Center
mi
from
Douglas, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Banner Thunderbird Medical Center
mi
from
Glendale, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Banner Baywood Medical Center
mi
from
Mesa, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Banner Baywood Medical Center
mi
from
Mesa, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Gila Health Resources
mi
from
Morenci, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Gila Health Resources
mi
from
Morenci, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Holy Cross Hospital
mi
from
Nogales, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Holy Cross Hospital
mi
from
Nogales, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Maricopa Medical Center
mi
from
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Maricopa Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
John C. Lincoln
mi
from
Phoenix, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
John C. Lincoln
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Mt. Graham Regional Medical Center
mi
from
Safford, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Mt. Graham Regional Medical Center
mi
from
Safford, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
San Carlos Indian Hospital
mi
from
San Carlos, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
San Carlos Indian Hospital
mi
from
San Carlos, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Tucson Medical Center
mi
from
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Tucson Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
University Medical Center
mi
from
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
St. Mary's Hospital
mi
from
Tucson, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
St. Mary's Hospital
mi
from
Tucson, AZ
Click here to add this to my saved trials
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated:  2/19/2011
Whiteriver IHS Hospital
mi
from
Whiteriver, AZ
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
Status: Enrolling
Updated: 2/19/2011
Whiteriver IHS Hospital
mi
from
Whiteriver, AZ
Click here to add this to my saved trials
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Status: Enrolling
Updated:  3/15/2011
Genesys East Flint Campus
mi
from
Burton, MI
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing Exacerbation
Status: Enrolling
Updated: 3/15/2011
Genesys East Flint Campus
mi
from
Burton, MI
Click here to add this to my saved trials
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Status: Enrolling
Updated:  3/28/2011
Mercy Center for Corrective Eye Surgery
mi
from
McHenry, IL
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia
Status: Enrolling
Updated: 3/28/2011
Mercy Center for Corrective Eye Surgery
mi
from
McHenry, IL
Click here to add this to my saved trials
Hydroxychloroquine Efficacy in Chronic Urticaria
Hydroxychloroquine Efficacy in Chronic Urticaria
Status: Enrolling
Updated:  4/11/2011
Vanderbilt University Allergy Sinus Asthma Program
mi
from
Nashville, TN
Hydroxychloroquine Efficacy in Chronic Urticaria
Hydroxychloroquine Efficacy in Chronic Urticaria
Status: Enrolling
Updated: 4/11/2011
Vanderbilt University Allergy Sinus Asthma Program
mi
from
Nashville, TN
Click here to add this to my saved trials
Cooling Pillow for Atopic Dermatitis
Novel Use of a Cooling Pillow for Treatment of Severe Hand and Neck Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
Northwestern University Department of Dermatology
mi
from
Chicago, IL
Cooling Pillow for Atopic Dermatitis
Novel Use of a Cooling Pillow for Treatment of Severe Hand and Neck Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Northwestern University Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Northwestern University, Feinberg School of Medicine, Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated:  4/29/2011
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Text Messaging and Atopic Dermatitis
The Use of Text Messages to Improve Adherence to Health Maintenance Behaviors in Adolescents With Atopic Dermatitis
Status: Enrolling
Updated: 4/29/2011
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Status: Enrolling
Updated:  5/25/2011
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
Status: Enrolling
Updated: 5/25/2011
University of California, Davis Department of Dermatology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated:  6/1/2011
Tucson Medical Center
mi
from
Tucson, AZ
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated: 6/1/2011
Tucson Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated:  6/1/2011
University Medical Center
mi
from
Tucson, AZ
Double-Blind, Alacramyn® vs. Placebo in Pediatric Patients
Prospective, Randomized, Double-Blind, Controlled Study of Alacramyn® vs. Placebo in Pediatric Patients With Systemic Signs of Scorpion Sting Envenomation
Status: Enrolling
Updated: 6/1/2011
University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Status: Enrolling
Updated:  6/20/2011
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
Status: Enrolling
Updated: 6/20/2011
Oregon Health & Science University Center for Health & Healing
mi
from
Portland, OR
Click here to add this to my saved trials
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms
Status: Enrolling
Updated:  6/21/2011
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
mi
from
New York, NY
Imiquimod 3.75% Cream in Combination With Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses
An Investigator-Initiated Study to Assess the Safety and Efficacy of Imiquimod 3.75% Cream When Used After Cryotherapy in the Treatment of Hypertrophic Actinic Keratoses (AK) on Dorsal Hands and Forearms
Status: Enrolling
Updated: 6/21/2011
Mount Sinai School of Medicine, Department of Dermatology, Clinical Trials
mi
from
New York, NY
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
AboutSkin Dermatology and DermSurgery, PC
mi
from
Englewood, CO
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
AboutSkin Dermatology and DermSurgery, PC
mi
from
Englewood, CO
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
Dermatology, Laser & Vein Specialists of the Carolinas PLLC
mi
from
Charlotte, NC
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
Dermatology, Laser & Vein Specialists of the Carolinas PLLC
mi
from
Charlotte, NC
Click here to add this to my saved trials
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated:  7/19/2011
Tennessee Clinical Research Center
mi
from
Nashville, TN
Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
An Exploratory, Open-label Study of Sequential Field-directed Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy
Status: Enrolling
Updated: 7/19/2011
Tennessee Clinical Research Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Status: Enrolling
Updated:  8/3/2011
Image Dermatology P.C.
mi
from
Montclair, NJ
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo
Status: Enrolling
Updated: 8/3/2011
Image Dermatology P.C.
mi
from
Montclair, NJ
Click here to add this to my saved trials